ArticleJournal of oncology2010

Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.

Angelo Corti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.